Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/11/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 15k | $0.97 | $14.5k | | 08/11/2022 |
06/15/2022 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 15k | $0.99 | $14.8k | | 06/15/2022 |
05/26/2022 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 40k | $0.50 | $20k | | 05/26/2022 |
09/09/2021 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 15k | $2.60 | $39k | | 09/09/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 948.2k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Purchase | Common Stock | 48k | $15.00 | $719.7k | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 916.6k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Purchase | Common Stock | 46.4k | $15.00 | $695.7k | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 272.1k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 352k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 525.7k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Purchase | Common Stock | 26.6k | $15.00 | $399.1k | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Common Stock | 244.4k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Purchase | Common Stock | 12.4k | $15.00 | $185.5k | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 3.6M | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 3.5M | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 1M | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 1.3M | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 2M | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series A-1 Preferred Stock | 936k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 309.3k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 299k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 88.8k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 114.8k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 171.5k | $0.00 | $0 | See footnotes | 08/02/2021 |
08/02/2021 | Icosavax, Inc. | ICVX | Conversion | Series B-1 Preferred Stock | 79.7k | $0.00 | $0 | See footnotes | 08/02/2021 |
06/15/2021 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 15k | $2.74 | $41.1k | | 06/15/2021 |
05/27/2021 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 40k | $2.59 | $103.6k | | 05/27/2021 |
12/31/2020 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 4.5k | $3.46 | $15.6k | | 12/31/2020 |
09/30/2020 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 4.6k | $3.38 | $15.6k | | 09/30/2020 |
06/30/2020 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 3.7k | $4.17 | $15.6k | | 06/30/2020 |
06/09/2020 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 15k | $3.27 | $49k | | 06/09/2020 |
05/20/2020 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 40k | $3.84 | $153.6k | | 05/20/2020 |
03/31/2020 | Aptinyx Inc. | APTX | Grant | Stock Option (Right to Buy) | 7.4k | $2.16 | $15.9k | | 03/31/2020 |
03/19/2020 | Corvus Pharmaceuticals, Inc. | CRVS | Grant | Stock Option (Right to Buy) | 15k | $2.00 | $30k | | 03/19/2020 |
|